Kiniksa Pharmaceuticals
KNSA
KNSA
55 hedge funds and large institutions have $363M invested in Kiniksa Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 14 closing their positions.
Holders
55
Holders Change
+14
Holders Change %
+34.15%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
28
Increased
10
Reduced
10
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
ACH
1
ArrowMark Colorado Holdings
Denver,
Colorado
|
$26.5M |
2 |
2
BlackRock
New York
|
$11.5M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$14.2M |
4 |
VMI
4
VHCP Management III
New York
|
$8.36M |
5 |
5
Millennium Management
New York
|
$5.66M |